Symptoms
Common signs and symptoms of Ductal Carcinoma In Situ (DCIS) include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Ductal Carcinoma In Situ (DCIS).
The exact cause of DCIS remains unclear, but researchers understand that it develops when cells lining the milk ducts undergo genetic changes that cause them to grow abnormally.
The exact cause of DCIS remains unclear, but researchers understand that it develops when cells lining the milk ducts undergo genetic changes that cause them to grow abnormally. These genetic mutations can happen spontaneously over time or result from inherited factors. Unlike invasive breast cancer, DCIS cells lack the ability to break through the duct walls and spread to other parts of the breast or body.
Hormone exposure appears to play a significant role in DCIS development.
Hormone exposure appears to play a significant role in DCIS development. Estrogen and progesterone can stimulate breast cell growth, and prolonged exposure to these hormones throughout a woman's lifetime may increase the likelihood of cellular changes. This explains why factors like early menstruation, late menopause, and hormone replacement therapy can influence risk.
Age represents the strongest risk factor, with most cases occurring in women over 40.
Age represents the strongest risk factor, with most cases occurring in women over 40. As we age, our cells accumulate more genetic damage from normal wear and tear, environmental exposures, and other factors. The improved detection through mammography screening has also led to more DCIS diagnoses in recent decades, as many cases would have gone unnoticed in the past.
Risk Factors
- Being over age 40
- Family history of breast or ovarian cancer
- Previous breast biopsy showing abnormal cells
- Dense breast tissue on mammograms
- BRCA1 or BRCA2 gene mutations
- Early menstruation before age 12
- Late menopause after age 55
- Never having children or first pregnancy after 30
- Long-term hormone replacement therapy use
- Previous radiation therapy to chest area
Diagnosis
How healthcare professionals diagnose Ductal Carcinoma In Situ (DCIS):
- 1
DCIS diagnosis typically begins when a mammogram reveals suspicious areas like tiny calcium deposits called microcalcifications or unusual tissue density patterns.
DCIS diagnosis typically begins when a mammogram reveals suspicious areas like tiny calcium deposits called microcalcifications or unusual tissue density patterns. Since most cases don't cause symptoms, routine screening mammograms catch the majority of DCIS cases. When radiologists spot concerning changes, they'll recommend additional imaging tests like diagnostic mammograms with magnification views or breast ultrasound to get a clearer picture.
- 2
A tissue biopsy provides the definitive diagnosis for DCIS.
A tissue biopsy provides the definitive diagnosis for DCIS. Doctors usually perform a core needle biopsy, using imaging guidance to target the suspicious area and remove small tissue samples for laboratory analysis. The pathologist examines these samples under a microscope to determine whether abnormal cells are present and confined to the ducts. Sometimes an MRI scan helps evaluate the extent of DCIS throughout the breast.
- 3
Once DCIS is confirmed, doctors grade it based on how abnormal the cells appear and how quickly they're growing.
Once DCIS is confirmed, doctors grade it based on how abnormal the cells appear and how quickly they're growing. Low-grade DCIS looks more like normal cells and grows slowly, while high-grade DCIS appears more abnormal and tends to grow faster. The pathologist also checks for hormone receptors on the cancer cells, which helps guide treatment decisions. Additional tests may include examining the margins around the biopsy site to determine how widespread the DCIS might be.
Complications
- The most significant concern with DCIS is its potential to progress to invasive breast cancer if left untreated.
- Studies suggest that without treatment, roughly 20 to 30 percent of high-grade DCIS cases may eventually develop into invasive cancer over 10 years, while low-grade DCIS progresses less frequently.
- This risk varies considerably based on factors like the grade of DCIS, patient age, and hormone receptor status.
- Treatment itself can sometimes lead to complications, though serious problems are uncommon.
- Surgery may result in changes to breast appearance, temporary or permanent numbness, and rarely, infection or bleeding.
- Radiation therapy can cause skin irritation similar to sunburn, fatigue, and long-term changes in breast texture or color.
- Hormone therapy side effects might include menopausal symptoms, mood changes, and small increases in risks of blood clots or endometrial cancer.
- Most women find these side effects manageable and temporary, with the benefits of treatment far outweighing the risks.
Prevention
- Primary prevention of DCIS focuses on reducing modifiable risk factors and maintaining overall breast health.
- Regular physical activity, maintaining a healthy weight, and limiting alcohol consumption may help reduce breast cancer risk overall.
- Women should aim for at least 150 minutes of moderate exercise weekly and limit alcohol to one drink per day or less, as both factors can influence hormone levels and cellular health.
- Screening mammograms represent the most effective tool for early DCIS detection, though they don't prevent the condition itself.
- Women should follow recommended screening guidelines, typically starting annual mammograms at age 40 or as advised by their healthcare provider.
- Those with higher risk due to family history or genetic factors may need earlier or more frequent screening.
- Dense breast tissue can make mammograms less effective, so additional screening methods like breast MRI might be recommended for high-risk women.
- Genetic counseling and testing may benefit women with strong family histories of breast or ovarian cancer.
- Those who test positive for BRCA mutations or other high-risk genetic variants might consider enhanced screening, chemoprevention with medications like tamoxifen, or even preventive surgery in extreme cases.
- Lifestyle modifications like maintaining a healthy diet rich in fruits and vegetables, avoiding unnecessary hormone supplementation, and staying physically active can support overall health and potentially reduce cancer risk.
Treatment for DCIS aims to remove all abnormal cells and reduce the risk of recurrence or progression to invasive cancer.
Treatment for DCIS aims to remove all abnormal cells and reduce the risk of recurrence or progression to invasive cancer. Surgery represents the primary treatment, with two main options available. Lumpectomy involves removing the DCIS along with a small margin of healthy tissue around it, preserving most of the breast. Mastectomy removes the entire breast and is typically recommended when DCIS is extensive, multifocal, or when lumpectomy cannot achieve clear margins.
Radiation therapy often follows lumpectomy to destroy any remaining abnormal cells in the breast tissue.
Radiation therapy often follows lumpectomy to destroy any remaining abnormal cells in the breast tissue. Treatment typically involves daily radiation sessions for five to six weeks, though newer techniques like accelerated partial breast irradiation can shorten this timeframe. Research shows that radiation reduces the risk of DCIS recurrence by about half. However, radiation isn't always necessary, particularly for small, low-grade DCIS with clear surgical margins.
Hormone therapy may be recommended for women whose DCIS tests positive for estrogen receptors.
Hormone therapy may be recommended for women whose DCIS tests positive for estrogen receptors. Medications like tamoxifen can block estrogen's effects on breast tissue, reducing the risk of developing new breast cancers. Treatment typically lasts five years and can reduce breast cancer risk by approximately 40 percent. Side effects may include hot flashes, mood changes, and a small increased risk of blood clots.
Active surveillance is being studied as an alternative to immediate surgery for certain low-risk DCIS cases.
Active surveillance is being studied as an alternative to immediate surgery for certain low-risk DCIS cases. This approach involves close monitoring with frequent mammograms and clinical exams rather than immediate treatment. While still considered experimental, early research suggests that some very low-grade DCIS cases may be safely watched rather than treated immediately. However, this approach requires careful patient selection and close medical supervision.
Living With Ductal Carcinoma In Situ (DCIS)
Living with a DCIS diagnosis often involves adjusting to a new normal that includes regular medical follow-up and ongoing awareness of breast health. Most women return to their usual activities within a few weeks after treatment, though recovery timelines vary depending on the type of surgery and whether radiation therapy was needed. Following treatment, regular mammograms and clinical breast exams become even more important for detecting any changes early.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 24, 2026v1.0.0
- Published by DiseaseDirectory